Elena Conca

Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan

Chiara Cremolini, Daniele Rossini, Emanuela Dell’Aquila et al. · JAMA Oncology · 2018 · 397 citations · Full text

Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect

Silvia Stacchiotti, Tiziana Negri, Nadia Zaffaroni et al. · Annals of Oncology · 2011 · 219 citations · Full text

Medicine, Pathology, Direct Antitumor Effect +4

KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors

Claudia Miranda, Martina Nucifora, Francesca Molinari et al. · Clinical Cancer Research · 2012 · 178 citations

Phase II study on lapatinib in advanced EGFR-positive chordoma

Silvia Stacchiotti, Elena Tamborini, Salvatore Lo Vullo et al. · Annals of Oncology · 2013 · 143 citations · Full text

Tumoral Pathology, Medicine, Pathology +4

Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O⁶-Methylguanine–DNA Methyltransferase–Silenced Metastatic Colorectal Cancer: The MAYA Trial

Federica Morano, Alessandra Raimondi, Filippo Pagani et al. · Journal of Clinical Oncology · 2022 · 120 citations · Full text